Related Experiment Video
Updated: Jun 7, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
[Obesity in childhood]
Summary
Childhood obesity is a growing concern, defined by specific criteria and affecting prevalence. This review covers causes, complications like metabolic syndrome, and current treatment approaches for pediatric obesity.
Area of Science:
- Pediatrics
- Endocrinology
- Cardiology
- Gastroenterology
Background:
- Childhood obesity is a significant public health issue with increasing prevalence worldwide.
- Obesity in children and adolescents is linked to serious health complications, including cardiovascular and metabolic syndromes, and nonalcoholic fatty liver disease.
- Understanding the multifaceted causes of pediatric obesity, including genetics, hormonal factors, and lifestyle influences, is crucial.
Purpose of the Study:
- To present current data on the definition, prevalence, and diagnostic criteria for childhood obesity and metabolic syndrome.
- To analyze the etiological factors contributing to obesity in children and adolescents.
- To review the relationship between obesity and its associated comorbidities, and to discuss modern treatment strategies.
Main Methods:
- Review of modern scientific literature and data.
- Analysis of diagnostic criteria for obesity and metabolic syndrome.
- Synthesis of expert opinions from various medical specialists.
Main Results:
- The article defines childhood obesity and its prevalence, outlining diagnostic criteria for obesity and metabolic syndrome.
- Genetic, hormonal, and lifestyle factors are identified as key contributors to childhood obesity.
- Strong associations between obesity and conditions such as cardiovascular disease, metabolic syndrome, and nonalcoholic fatty liver disease are discussed.
Conclusions:
- Childhood obesity is a complex condition with significant health implications requiring a multidisciplinary approach.
- Accurate diagnosis and understanding of contributing factors are essential for effective management.
- Current treatment strategies for pediatric obesity are presented, emphasizing the need for continued research and intervention.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:23Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...